From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approves hormone treatment for hypoparathyroidism

from Pharmacy Times

The FDA has approved NPS Pharmceuticals’ parathyroid hormone, a once-daily hormonal injection to control low blood calcium levels in patients with hypoparathyroidism. Hypoparathyroidism is a disease in which the parathyroid glands produce an insufficient amount of parathyroid hormone, which helps to regulate calcium and phosphorus levels in the body. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063